Inventor · disambiguated record
Yuanbo Qin
Also filed as: QIN YUANBO
6 granted patents·4 pending applications·0 citations·filing 2018–2022
65Inventor score
Top patents by PatentIndex Score
10 records- 0171US12152259B2Modified CAS9 protein, and use thereofUNIV TOKYO·Filed 2022·Granted Nov 26, 2024·0 cites·15 claims
- 0258US11530396B2Modified CAS9 protein, and use thereofUNIV TOKYO·Filed 2018·Granted Dec 20, 2022·0 cites·25 claims
- 0358US11473071B2Method for treating muscular dystrophy by targeting utrophin geneASTELLAS PHARMA INC·Filed 2021·Granted Oct 18, 2022·0 cites·17 claims
- 0451US2023323456A1Method for treating facioscapulohumeral muscular dystrophy (fshd) by targeting dux4 geneMODALIS THERAPEUTICS CORP·Filed 2021·Application pending·0 cites
- 0550US12502418B2Method for treating muscular dystrophy by targeting LAMA1 geneMODALIS THERAPEUTICS CORP·Filed 2020·Granted Dec 23, 2025·0 cites·13 claims
- 0643US11439692B2Method of treating diseases associated with MYD88 pathways using CRISPR-GNDM systemMODALIS THERAPEUTICS CORP·Filed 2018·Granted Sep 13, 2022·0 cites·17 claims
- 0742US2021246473A1Modified cas9 protein, and use thereofMODALIS THERAPEUTICS CORP·Filed 2019·Application pending·0 cites
- 0841US2021332094A1Novel transcription activatorMODALIS THERAPEUTICS CORP·Filed 2019·Application pending·0 cites
- 0940US11591621B2Method of treating diseases associated with elevated KRAS expression using CRISPR-GNDM systemMODALIS THERAPEUTICS CORP·Filed 2018·Granted Feb 28, 2023·0 cites·8 claims
- 1040US2022017881A1MODIFIED Cas9 PROTEIN AND USE THEREOFMODALIS THERAPEUTICS CORP·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yuanbo Qin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →